MA26266A1 - Preparations topiques de brivudine stabilisees - Google Patents

Preparations topiques de brivudine stabilisees

Info

Publication number
MA26266A1
MA26266A1 MA27219A MA27219A MA26266A1 MA 26266 A1 MA26266 A1 MA 26266A1 MA 27219 A MA27219 A MA 27219A MA 27219 A MA27219 A MA 27219A MA 26266 A1 MA26266 A1 MA 26266A1
Authority
MA
Morocco
Prior art keywords
brivudine
preparations
stabilized topical
topical
stabilized
Prior art date
Application number
MA27219A
Other languages
English (en)
Inventor
Ulrike Gehlert
Karsten Groger
Reiuhard Schmtz
Karl-Heinz Schrader
Andreas Schrader
Marc Wihsmann
Carlo Alberto Maggi
Stefano Manzini
Bettina Stubinski
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of MA26266A1 publication Critical patent/MA26266A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA27219A 2001-01-17 2003-06-30 Preparations topiques de brivudine stabilisees MA26266A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01100968 2001-01-17

Publications (1)

Publication Number Publication Date
MA26266A1 true MA26266A1 (fr) 2004-09-01

Family

ID=8176229

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27219A MA26266A1 (fr) 2001-01-17 2003-06-30 Preparations topiques de brivudine stabilisees

Country Status (28)

Country Link
US (1) US20040087602A1 (fr)
EP (1) EP1365772A2 (fr)
JP (1) JP2004519460A (fr)
KR (1) KR20030070109A (fr)
CN (1) CN1236777C (fr)
AR (1) AR035530A1 (fr)
AU (1) AU2002244642B2 (fr)
BG (1) BG107988A (fr)
BR (1) BR0206478A (fr)
CA (1) CA2434743A1 (fr)
CZ (1) CZ20031912A3 (fr)
EE (1) EE200300322A (fr)
HR (1) HRP20030559A2 (fr)
HU (1) HUP0302741A3 (fr)
IL (1) IL156933A0 (fr)
MA (1) MA26266A1 (fr)
MX (1) MXPA03006307A (fr)
MY (1) MY136633A (fr)
NO (1) NO20033206D0 (fr)
PE (1) PE20020818A1 (fr)
PL (1) PL365741A1 (fr)
RU (1) RU2280453C2 (fr)
SK (1) SK8992003A3 (fr)
TN (1) TNSN03036A1 (fr)
UA (1) UA80673C2 (fr)
WO (1) WO2002056913A2 (fr)
YU (1) YU57103A (fr)
ZA (1) ZA200305437B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
FR2936706B1 (fr) * 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
JP5591128B2 (ja) * 2009-01-29 2014-09-17 大日本住友製薬株式会社 内核を有する口腔内崩壊錠
KR102401145B1 (ko) * 2015-03-19 2022-05-23 다이이찌 산쿄 가부시키가이샤 착색제를 함유하는 고형 제제
CN104988791A (zh) * 2015-06-25 2015-10-21 广东义晟实业有限公司 一种抗病毒添加剂及添加该添加剂的胶水和uv漆

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072137A1 (fr) * 1981-08-01 1983-02-16 Beecham Group Plc Déoxyuridines à activité antivirale
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
DE4122337A1 (de) * 1991-07-05 1993-01-14 Cedona Pharm Bv Pharmazeutische zubereitung
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
GB9521454D0 (en) * 1995-10-19 1995-12-20 Kappa Pharmaceuticals Ltd Compositions for the treatment of conditions caused by herpes virus
US6558710B1 (en) * 1999-06-14 2003-05-06 Helen Rebecca Godfrey Topical zinc compositions and methods of use
DE10162593A1 (de) * 2001-12-19 2003-07-03 Menarini Ricerche Spa Stabilisierte topische Brivudin-Formulierungen

Also Published As

Publication number Publication date
CN1236777C (zh) 2006-01-18
CZ20031912A3 (cs) 2004-01-14
UA80673C2 (en) 2007-10-25
EP1365772A2 (fr) 2003-12-03
WO2002056913A2 (fr) 2002-07-25
EE200300322A (et) 2003-10-15
NO20033206L (no) 2003-07-15
PL365741A1 (en) 2005-01-10
TNSN03036A1 (en) 2005-04-08
HUP0302741A3 (en) 2007-06-28
AR035530A1 (es) 2004-06-02
MXPA03006307A (es) 2003-09-16
CA2434743A1 (fr) 2002-07-25
IL156933A0 (en) 2004-02-08
RU2003121639A (ru) 2005-02-10
RU2280453C2 (ru) 2006-07-27
AU2002244642B2 (en) 2005-12-15
HUP0302741A2 (hu) 2003-11-28
ZA200305437B (en) 2004-07-15
JP2004519460A (ja) 2004-07-02
SK8992003A3 (en) 2003-11-04
MY136633A (en) 2008-11-28
CN1486185A (zh) 2004-03-31
NO20033206D0 (no) 2003-07-15
US20040087602A1 (en) 2004-05-06
KR20030070109A (ko) 2003-08-27
WO2002056913A3 (fr) 2002-11-07
HRP20030559A2 (en) 2005-06-30
BR0206478A (pt) 2003-12-30
BG107988A (bg) 2004-09-30
PE20020818A1 (es) 2002-10-21
YU57103A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
DK1314437T3 (da) Stabiliserede antistofindeholdende præparater
NO20033556D0 (no) Farmasöytiske preparater
IS6040A (is) Valdekoxib efnablöndur
DK1421841T3 (da) Mejetærsker
NO20003967L (no) Farmasöytiske preparater
DE59913150D1 (de) Spektrometer
DE10084057D2 (de) Miniaturisiertes Spektrometer
DE60106275T8 (de) Dermatologische zusammensetzung
DE50106743D1 (de) Abgassystem
DK0988861T3 (da) Stabiliserede proteinpræparater
ATE552577T1 (de) Duales mautsystem
DE60218346D1 (de) Stabilisierte topische brivudin-formulierungen
DE60231590D1 (de) Haarfärbeverfahren
DE60335019D1 (de) Topische hautpräparate
DE60220505D1 (de) Haarwaschmittel
ITMI20011532A0 (it) Cosmetico solido
ATE246494T1 (de) Brausezubereitungen
DE60232960D1 (de) Mundharmonikakamm
MA26266A1 (fr) Preparations topiques de brivudine stabilisees
DE60214042D1 (de) Nass-trocken-reinigungssystem
DE50211902D1 (de) Systemteil
DK199900492A (da) Spektrometer
ITRM20010334A1 (it) Marmitta di scarico
FR2792409B1 (fr) Spectrometre
ATE256754T1 (de) Gerbstoff-/nachgerbstoffpräparationen